Ocular application of chitosan

Bibliography

• Toit L, Pillay V, Choonara YE, Ocular drug delivery - a look towards nanobioadhesives. Expert Opin Drug Deliv 2011;8(1):71-94
   PubMed Web of Science ®Google Scholar
• Cao F, Wanga Y, Ping Q, Zn–Al–NO3-layered double hydroxides with intercalated diclofenac for ocular delivery. Int J Pharm 2011;404:250-6
   PubMed Web of Science ®Google Scholar
• Araujo J, Gonzalez E, Egea MA, Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomed Nanotechnol 2009;5:394-401
   PubMed Web of Science ®Google Scholar
• Fuente M, Ravina M, Paolicelli P, Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 2010;62:100-17
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Freitas O, Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Eur J Pharm Biopharm 2011;79:320-7
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Suzuki M, Kusai A, Synergistic effect of EDTA and boric acid on corneal penetration of CS-088. Int J Pharm 2005;290:83-9
   PubMed Web of Science ®Google Scholar
• Shen J, Wang Y, Ping Q, Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 2009;137:217-23
   PubMed Web of Science ®Google Scholar
• Granero G, Longhi MR. Promising complexes of acetazolamide for topical ocular administration. Expert Opin Drug Deliv 2010;7(8):943-53
   PubMed Web of Science ®Google Scholar
• Lee TWY, Robinson JR. Ocular penetration enhancers. In: Mitra AK, editor. Ophthalmic Drug Delivery Systems. Marcel Dekker, Inc.; USA: 2003. p. 281-309
   Google Scholar
• Li N, Zhuang C, Wang M, Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 2009;379:131-8
   PubMed Web of Science ®Google Scholar
• Yuan X, Li H, Yuan Y. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydr Polym 2006;65:337-45
   Web of Science ®Google Scholar
• Wang S, Zhang J, Jiang T, Protective effect of Coenzyme Q10 against oxidative damage in human lens epithelial cells by novel ocular drug carriers. Int J Pharm 2011;403:219-29
   PubMed Web of Science ®Google Scholar
• Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005;57:1595-639
   PubMed Web of Science ®Google Scholar
• Felt O, Furrer P, Mayer JM, Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm 1999;180:185-93
   PubMed Web of Science ®Google Scholar
• Rupenthal ID, Green CR, Alany RG. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int J Pharm 2011;411:69-77
   PubMed Web of Science ®Google Scholar
• Santvliet LV, Ludwig A. The influence of penetration enhancers on the volume instilled of eye drops. Eur J Pharm Biopharm 1998;45:189-98
   PubMed Web of Science ®Google Scholar
• Lopes LB, Collerr JH, Vitoria M, Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur J Pharm Biopharm 2005;60:25-30
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Rocha EM, A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 2010;75:186-93
   PubMed Web of Science ®Google Scholar
• Johnston TP, Dias CS, Mitra AK. Mucoadhesive polymers in ophthalmic drug delivery. In: Mitra AK, editor. Ophthalmic Drug Delivery Systems. Marcel Dekker, Inc.; USA: 2003. p. 409-35
   Google Scholar
• Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 2003;255:13-32
   PubMed Web of Science ®Google Scholar
• De Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 2001;224:159-68
   PubMed Web of Science ®Google Scholar
• Basaran E, Demirel M, Sırmagul B, Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 2010;27(1):37-47
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhao J, Zhang X, Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 2011;403:185-91
   PubMed Web of Science ®Google Scholar
• Mahmoud AA, El-Feky GS, Kamel R, Chitosan/sulfobutylether–cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm 2011;413:229-36
   PubMed Web of Science ®Google Scholar
• Hagigit T, Abdulrazik M, Orucov F, Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye. J Control Release 2010;145:297-305
   PubMed Web of Science ®Google Scholar
• Pignatello R, Ferro M, De Guidi G, 2Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100® and RL100®.. Int J Pharm 2001;218:27-42
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Ferrara P, Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 2002;16:53-61
   PubMed Web of Science ®Google Scholar
• Basaran E, Demirel M, Sırmagul B, Polymeric cyclosporine-A nanoparticles for ocular application. J Biomed Nanotechnol 2011;7:714-23
   PubMed Web of Science ®Google Scholar
• Meng J, Sturgis TF, Youan BBC. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci 2011;44:57-67
   PubMed Web of Science ®Google Scholar
• Raymond C Rowe, Paul J Sheskey, Marian E Quinn. Chitosan. In: Rowe RC, Sheskey PJ, Quinn ME, editors, Pharmaceutical Excipients, RPS Publishing; USA: 2009. p. 159-61
   Google Scholar
• Yenilmez E, Basaran E, Yazan Y. Release characteristics of vitamin E incorporated chitosan microspheres and in vitro–in vivo evaluation for topical application. Carbohydr Polym 2011;84:807-11
   Web of Science ®Google Scholar
• Gong K, Darr JA, Rehman IU. Supercritical fluid assisted impregnation of indomethacin into chitosan thermosets for controlled release applications. Int J Pharm 2006;315:93-8
   PubMed Web of Science ®Google Scholar
• Gibson M. Ophthalmic dosage forms. In: Gibson M, editor. Pharmaceutical Preformulation and Formulation. CRC Press LLC; Florida-USA: 2004. p. 461-91
   Google Scholar
• Hosoya K, Lee VHL, Kim K-J. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm 2005;60:227-40
   PubMed Web of Science ®Google Scholar
• Layers of cornea by Lutz Slomianka. Available from: http://www.lab.anhb.uwa.edu.au/mb140/corepages/eye/eye.htm [Last accessed 7 February 2012]
   Google Scholar
• Jones D. Ocular, nasal and otic dosage forms. In: Jones D, editor. Pharmaceutics –Dosage Form and Design. RPS Publishing; USA: 2008. p. 135-56
   Google Scholar
• Majumdar S, Hippalgaonkar K, Repka MA. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea. Int J Pharm 2008;348:175-8
   PubMed Web of Science ®Google Scholar
• Chastain JE. Ophthalmic drugs. In: Mitra AK, editor. Ophthalmic Drug Delivery Systems. Marcel Dekker, Inc.; USA: 2003. p. 59-107
   Google Scholar
• Tamilvanan S, Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm 2004;58:357-68
   PubMed Web of Science ®Google Scholar
• Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release 2003;89:151-65
   PubMed Web of Science ®Google Scholar
• Guibal E. Heterogeneous catalysis on chitosan-based materials: a review. Prog Polym Sci 2005;30:71-109
   Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TA. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100:5-28
   PubMed Web of Science ®Google Scholar
• Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 2010;56:290-9
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomed Nanotechnol 2010;6:144-52
   PubMed Web of Science ®Google Scholar
• Casettari L, Vllasaliu D, Castagnino E, PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications. Prog Polym Sci 2011; doi:10.1016/j.progpolymsci.2011.10.001
   PubMed Web of Science ®Google Scholar
• Dodane V, Vilivalam VD. Pharmaceutical applications of chitosan. PSTT 1998;1(6):246-53
   Google Scholar
• Hu Y-L, Qi W, Han F, Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomed 2011;6:3351-9
   PubMed Web of Science ®Google Scholar
• Calvo P, Vila-Jato JL, Alonso M. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 1997;153:41-50
   Web of Science ®Google Scholar
• De Campos AM, Sanchez A, Gref R, The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 2003;20:73-81
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Kant S, Maiti P, Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 2009;136:2-13
   PubMed Web of Science ®Google Scholar
• Wang L-Y, Ma G-H, Su Z-G, Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug. J Control Release 2005;106:62-75
   PubMed Web of Science ®Google Scholar
• FDA GRAS Claim Notification of Chitosan. Available from: http://www.accessdata.fda.gov/scripts/fcn/gras_notices/grn000073.pdf [Last accessed 6 February 2012]
   Google Scholar
• FDA Chitosan GRAS Notice. Available from: http://www.accessdata.fda.gov/scripts/fcn/gras_notices/GRN000397.pdf [Last accessed 6 February 2012]
   Google Scholar
• Asada M, Takahashi H, Okamoto H, Theophylline particle design using chitosan by the spray drying. Int J Pharm 2004;270:167-74
   PubMed Web of Science ®Google Scholar
• Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 2010;62:3-11
   PubMed Web of Science ®Google Scholar
• Yoksan R, Chirachanchai S. Amphiphilic chitosan nanosphere: studies on formation, toxicity, and guest molecule incorporation. Bioorgan Med Chem 2008;16:2687-96
   PubMed Web of Science ®Google Scholar
• Omara EA, Aly HF, Nada SA. Chitosan induced hepato-nephrotoxicity in mice with special reference to gender effect in glycolytic enzymes activities. Regul Toxicol Pharmacol 2012;62:29-40
   PubMed Web of Science ®Google Scholar
• Loh JW, Yeoh G, Saunders M, Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. Toxicol Appl Pharmacol 2010;249:148-57
   PubMed Web of Science ®Google Scholar
• Prego C, Torres D, Fernandez-Megia E, Chitosan–PEG nanocapsules as new carriers for oral peptide delivery Effect of chitosan pegylation degree. J Control Release 2006;111:299-308
   PubMed Web of Science ®Google Scholar
• Hu F-Q, Meng P, Dai Y-Q, PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm 2008;70:749-57
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol 2011;670:372-83
   PubMed Web of Science ®Google Scholar
• Di Colo G, Zambito Y, Burgalassi S, Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin. Int J Pharm 2004;273:37-44
   PubMed Web of Science ®Google Scholar
• Li XY, Kong XY, Wang XH, Gel–sol–gel thermo-gelation behavior study of chitosan–inorganic phosphate solutions. Eur J Pharm Biopharm 2010;75:388-92
   PubMed Web of Science ®Google Scholar
• Ur-Rehman T, Tavelin S, Grobner G. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels. Int J Pharm 2011;409:19-29
   PubMed Web of Science ®Google Scholar
• Shen J, Deng Y, Jin X, Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution. Int J Pharm 2010;402:248-53
   PubMed Web of Science ®Google Scholar
• Yuan X-B, Yuan Y-B, Jiang W, Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation. Int J Pharm 2008;349:241-8
   PubMed Web of Science ®Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008;68:513-25
   PubMed Web of Science ®Google Scholar
• Di Colo G, Zambito Y, Burgalassi S, Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Int J Pharm 2002;248:115-22
   PubMed Web of Science ®Google Scholar
• Zambito Y, Di Colo G. Thiolated quaternary ammonium–chitosan conjugates for enhanced precorneal retention, transcorneal permeation and intraocular absorption of dexamethasone. Eur J Pharm Biopharm 2010;75:194-9
   PubMed Web of Science ®Google Scholar
• Chenite A, Chaput C, Wang D, Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000;21:2155-61
   PubMed Web of Science ®Google Scholar
• Wu J, Su Z-G, Ma G-H. A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate. Int J Pharm 2006;315:1-11
   PubMed Web of Science ®Google Scholar
• Berger J, Reist M, Mayer JM, Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 2004;57:19-34
   PubMed Web of Science ®Google Scholar
• Berger J, Reist M, Mayer JM, Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur J Pharm Biopharm 2004;57:35-52
   PubMed Web of Science ®Google Scholar
• Wu H, Liu Z, Peng J, Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. Int J Pharm 2011;410:31-40
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang S. Topical use of Coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect. Int J Pharm 2009;372:66-75
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrin M, Saez V, Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007;28:1553-64
   PubMed Web of Science ®Google Scholar
• Jumaa M, Furkert FH, Muller BW. A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur J Pharm Biopharm 2002;53:115-23
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170-84
   PubMed Web of Science ®Google Scholar
• Li X, Nie S, Kong J, A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008;363:177-82
   PubMed Web of Science ®Google Scholar
• Rodrigues LB, Leite HF, Yoshida MI, In vitro release and characterization of chitosan films as dexamethasone carrier. Int J Pharm 2009;368:1-6
   PubMed Web of Science ®Google Scholar
• Available from: http://www.lab.anhb.uwa.edu.au/mb140/corepages/eye/eye.htm
   Google Scholar